Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion type Assertion NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_head.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion description "[Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_provenance.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion evidence source_evidence_literature NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_provenance.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion SIO_000772 15128051 NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_provenance.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion wasDerivedFrom gad-20150221 NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_provenance.
- NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_assertion wasGeneratedBy ECO_0000203 NP85439.RAY7Se3-6Y61J7_-7klea7cv1-TVEhW1qNm83O9VeVsqg130_provenance.